NCT00742092 - Miglustat in Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Cystic Fibrosis

Interventions

DRUG

miglustat

Oral miglustat capsules 200 mg t.i.d. (three times a day) for 7 days and a single 200 mg dose on Day 8

DRUG

placebo

Oral placebo capsules matching in appearance miglustat capsules given t.i.d. (three times a day) for 7 days and a single dose on Day 8

Trial Locations (1)

Universite Catholique de Louvain, Brussels